Market for Neurostimulation devices was valued around US$ 3.7 bn in 2015 and projected to expand around 8% CAGR over 2019 to 2025
Neurostimulation is the process of modulating the nervous system by means of neurostimulation devices to improve quality of life (QOL) patients suffering from epilepsy, pain, depression, parkinsonism etc., Neurostimulation devices work by intervening the body's nervous system by effecting the nerve signal conduction.
Major Key Players of the Neurostimulation Devices Market are:
Boston Scientific, Cyberonics, Medtronic and St. Jude Medical, and Nevro Corporation to name a few. For instance, in 2016, St. Jude medical unveiled Deep Brain Stimulator (DBS) in Europe market to treat patients suffering from Dystonia, Parkinson's disease, and tremor.
Read More @ https://www.openpr.com/news/2049555/neurostimulation-devices-market-is-set-to-experience
Neurostimulation is the process of modulating the nervous system by means of neurostimulation devices to improve quality of life (QOL) patients suffering from epilepsy, pain, depression, parkinsonism etc., Neurostimulation devices work by intervening the body's nervous system by effecting the nerve signal conduction.
Major Key Players of the Neurostimulation Devices Market are:
Read More @ https://www.openpr.com/news/2049555/neurostimulation-devices-market-is-set-to-experience
No comments:
Post a Comment